121,654 Shares in Agilon Health, Inc. $AGL Purchased by Alpine Global Management LLC

Alpine Global Management LLC purchased a new stake in Agilon Health, Inc. (NYSE:AGL) during the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 121,654 shares of the company’s stock, valued at approximately $84,000.

Several other institutional investors also recently bought and sold shares of the company. Wealthcare Advisory Partners LLC acquired a new stake in Agilon Health in the 3rd quarter worth about $26,000. LPL Financial LLC lifted its position in shares of Agilon Health by 213.4% in the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after acquiring an additional 30,000 shares in the last quarter. Krilogy Financial LLC purchased a new position in shares of Agilon Health in the fourth quarter valued at approximately $34,000. CIBC Bancorp USA Inc. acquired a new stake in shares of Agilon Health in the third quarter worth approximately $34,000. Finally, Merit Financial Group LLC acquired a new stake in shares of Agilon Health in the fourth quarter worth approximately $35,000.

Analyst Upgrades and Downgrades

AGL has been the subject of several research reports. Weiss Ratings cut Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 27th. Jefferies Financial Group upgraded Agilon Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $27.50 to $48.00 in a report on Thursday, May 7th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $72.00 target price (up from $37.50) on shares of Agilon Health in a research note on Friday, May 8th. Benchmark reaffirmed a “buy” rating and set a $95.00 target price (up from $13.00) on shares of Agilon Health in a report on Thursday, May 21st. Finally, TD Cowen reiterated a “hold” rating and issued a $55.00 target price (up from $17.00) on shares of Agilon Health in a research report on Monday, May 11th. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $58.73.

Agilon Health Trading Down 0.9%

Shares of Agilon Health stock opened at $112.79 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The stock’s 50 day simple moving average is $66.92 and its 200-day simple moving average is $34.01. The stock has a market cap of $1.88 billion, a P/E ratio of -5.23 and a beta of 3.02. Agilon Health, Inc. has a 1-year low of $7.48 and a 1-year high of $118.25.

Agilon Health (NYSE:AGL) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, beating the consensus estimate of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.38 billion. Analysts predict that Agilon Health, Inc. will post -3.5 EPS for the current fiscal year.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.